3-(6-chloronaphthalen-2-yl)sulfonyl-1-[4-[3-(2-methylimidazol-1-yl)propyl]piperidin-1-yl]propan-1-one
C25H30ClN3O3S — CID 24881190
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(6-chloronaphthalen-2-yl)sulfonyl-1-[4-[3-(2-methylimidazol-1-yl)propyl]piperidin-1-yl]propan-1-one
3-(6-chloronaphthalen-2-yl)sulfonyl-1-[4-[3-(2-methylimidazol-1-yl)propyl]piperidin-1-yl]propan-1-one (PubChem CID 24881190) has the molecular formula C25H30ClN3O3S and a molecular weight of 488.05 g/mol. Its IUPAC name is 3-(6-chloronaphthalen-2-yl)sulfonyl-1-[4-[3-(2-methylimidazol-1-yl)propyl]piperidin-1-yl]propan-1-one.
Molecular Properties
| Compound Name | 3-(6-chloronaphthalen-2-yl)sulfonyl-1-[4-[3-(2-methylimidazol-1-yl)propyl]piperidin-1-yl]propan-1-one |
|---|---|
| PubChem CID | 24881190 |
| Molecular Formula | C25H30ClN3O3S |
| Molecular Weight | 488.05 g/mol |
| Exact Mass | 487.17 |
| IUPAC Name | 3-(6-chloronaphthalen-2-yl)sulfonyl-1-[4-[3-(2-methylimidazol-1-yl)propyl]piperidin-1-yl]propan-1-one |
| SMILES | Cc1nccn1CCCC1CCN(C(=O)CCS(=O)(=O)c2ccc3cc(Cl)ccc3c2)CC1 |
| InChI | InChI=1S/C25H30ClN3O3S/c1-19-27-11-15-28(19)12-2-3-20-8-13-29(14-9-20)25(30)10-16-33(31,32)24-7-5-21-17-23(26)6-4-22(21)18-24/h4-7,11,15,17-18,20H,2-3,8-10,12-14,16H2,1H3 |
| InChIKey | GGXFCCYZSDQJMY-UHFFFAOYSA-N |
| XLogP | 4.88 |
| TPSA | 72.27 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 488.05 |
| LogP ≤ 5 | 4.88 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 24881190 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.